Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues

[1]  Esteban Pardo,et al.  Semantic segmentation of mFISH images using convolutional networks , 2018, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[2]  Ross B. Girshick,et al.  Focal Loss for Dense Object Detection , 2017, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[3]  Serge J. Belongie,et al.  Feature Pyramid Networks for Object Detection , 2016, 2017 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[4]  Martín Abadi,et al.  TensorFlow: Large-Scale Machine Learning on Heterogeneous Distributed Systems , 2016, ArXiv.

[5]  Sergey Ioffe,et al.  Inception-v4, Inception-ResNet and the Impact of Residual Connections on Learning , 2016, AAAI.

[6]  Jian Sun,et al.  Deep Residual Learning for Image Recognition , 2015, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[7]  Wei Liu,et al.  SSD: Single Shot MultiBox Detector , 2015, ECCV.

[8]  Ali Farhadi,et al.  You Only Look Once: Unified, Real-Time Object Detection , 2015, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[9]  Ed Schuuring,et al.  Fully Automated Fluorescent in situ Hybridization (FISH) Staining and Digital Analysis of HER2 in Breast Cancer: A Validation Study , 2015, PloS one.

[10]  E. Cho,et al.  Analysis of HER2 status in breast carcinoma by fully automated HER2 fluorescence in situ hybridization (FISH): comparison of two immunohistochemical tests and manual FISH , 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[11]  Yan Xu,et al.  Deep learning of feature representation with multiple instance learning for medical image analysis , 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP).

[12]  W. Jochum,et al.  Comparison of automated and manual FISH for evaluation of HER2 gene status on breast carcinoma core biopsies , 2013, BMC Clinical Pathology.

[13]  Geoffrey E. Hinton,et al.  ImageNet classification with deep convolutional neural networks , 2012, Commun. ACM.

[14]  L. Pecciarini,et al.  HER2 Testing in Gastric Cancer , 2011, Advances in anatomic pathology.

[15]  Manfred Dietel,et al.  HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing , 2010, Virchows Archiv.

[16]  J. Thiery,et al.  HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management? , 2007, British Journal of Cancer.

[17]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2006, Archives of pathology & laboratory medicine.

[18]  Greg Yothers,et al.  Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. , 2005, The New England journal of medicine.

[19]  David Grimes,et al.  Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Jean-Christophe Olivo-Marin,et al.  Extraction of spots in biological images using multiscale products , 2002, Pattern Recognit..

[21]  H. Moch,et al.  Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer. , 2001, Journal of the National Cancer Institute.

[22]  J. Fletcher,et al.  The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy. , 1999, Seminars in cancer biology.

[23]  J. Ross,et al.  The HER‐2/neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy , 1998, Stem cells.

[24]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.

[25]  D. Bright,et al.  Two‐dimensional top hat filter for extracting spots and spheres from digital images , 1987 .

[26]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[27]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[28]  Prabhakar R. Gudla,et al.  SpotLearn: Convolutional Neural Network for Detection of Fluorescence In Situ Hybridization (FISH) Signals in High-Throughput Imaging Approaches. , 2017, Cold Spring Harbor symposia on quantitative biology.

[29]  Guigang Zhang,et al.  Deep Learning , 2016, Int. J. Semantic Comput..

[30]  Carolina Gutierrez,et al.  HER2: biology, detection, and clinical implications. , 2011, Archives of pathology & laboratory medicine.